Skip to content

Prohibited pharmaceutical

bambuterol

CAS 81732-65-2
12

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

Bambuterol is a prescription asthma medication, not a skincare ingredient. The EU bans it from cosmetics because it can affect the heart and nervous system when absorbed.

Skin benefits

  • Used as a prescription bronchodilator drug for asthma
  • Not an ingredient in legitimate cosmetics

Known concerns

  • Banned in EU cosmetics (Annex II) as a pharmaceutical substance
  • Beta-2 adrenergic agonist with systemic cardiovascular effects
  • Risk of palpitations, tremor, and metabolic changes if absorbed
  • Not assessed for any topical cosmetic use

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Related prohibited pharmaceuticals

12
norfenefrine
Prohibited pharmaceutical
 8
Furfuryltrimethyl ammonium salts, e.g. furtrethonium iodide (INN)
Prohibited pharmaceutical
 5
5,5-Diphenyl-4-imidazolidone (Doxenitoin (INN))
Prohibited pharmaceutical
 5
Carbromal (INN)
Prohibited pharmaceutical
 5
Metheptazine (INN) and its salts
Prohibited pharmaceutical
 3
Phenylpropanolamine hydrochloride [USAN:INN:BAN]
Prohibited pharmaceutical

Check your shelf

Find bambuterol in your products.

Scan any cosmetic product with LuxSense to see if it contains bambuterol and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.